EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Tumor neoantigen gene C7orf50 remodels the immune microenvironment by recruiting tumor-associated macrophages to promote hepatocellular carcinoma progression and lung metastasis

Jia Li, Xinming Ye, Sheng Su, Zhiqiang Hu, Changzhou Chen, Yu Gong, Zehuan Li, Feng Qi, Hecheng Li, Li Mao, Xiaowu Huang

Journal for ImmunoTherapy of Cancer · 2026

DOI: 10.1136/jitc-2025-011997 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2026. Verfasst von Jia Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Cancer Invasion, Zhongshan Hospital Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Tumor Microenvironment, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Yangfan Project of Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatocellular carcinoma (HCC) is a global health challenge with high mortality rates, particularly in patients with advanced disease and lung metastasis. T-cell receptor (TCR)-T cell therapy based on specific neoantigens, is an emerging treatment with potential for HCC. However, the prognosis of patients remains poor, underscoring the need for novel targets and strategies.

Methods

We conducted a comprehensive study to investigate the role of C7orf50 and its neoantigens in HCC. We evaluated the functional impact on HCC progression and metastasis in vitro and in vivo , and further explored the mechanism by which C7orf50 promotes cancer metastasis and remodels tumor immune environment. Using exome and transcriptome sequencing, we identified neoantigens associated with C7orf50 and assessed their potential in TCR-T therapy.

Results

Our in vitro experiments revealed that C7orf50 overexpression enhances HCC cell proliferation, migration, and invasion, while knockdown inhibits these processes. In vivo , C7orf50 promoted tumor growth and lung metastasis, with a significant correlation between C7orf50 expression and poor clinical outcomes in patients with HCC. We further demonstrated that C7orf50 activates the NF-κB/PAI-1 pathway by binding to AEG-1 and facilitating its nuclear translocation, thereby promoting tumor-associated macrophage recruitment. Meanwhile, we found that TCR-T from C7orf50 -related neoantigen could obviously realize the killing effect on HCC cells, revealing its great role in cell therapy.

Conclusion

C7orf50 is a critical mediator of HCC progression and lung metastasis, acting through the NF-κB/PAI-1 pathway and AEG-1. Its expression levels, along with those of PAI-1 and CD68, serve as independent prognostic markers. And C7orf50 -related neoantigen shows great application potential in TCR-T therapy. These findings provide a foundation for developing C7orf50 -targeted therapies and highlight its potential in precision medicine and immunotherapy for HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularTumor MicroenvironmentLung NeoplasmsTumor-Associated MacrophagesAntigens, NeoplasmHumansAnimalsMiceDisease ProgressionCell Line, TumorMaleFemale

Stichwörter der Autor:innen

Hepatocellular CarcinomaImmunotherapyMacrophageTumor microenvironment - TME

Substanzen

Antigens, Neoplasm

Autor:innen und Institutionen

  • Key Laboratory of Carcinogenesis and Cancer Invasion, Zhongshan Hospital Fudan University, Shanghai, China.
  • Department of Thoracic Surgery, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China.
  • Department of Oncology, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China huang.xiaowu@zs-hospital.sh.cn sysuncml@163.com lihecheng2000@hotmail.com qf12486@rjh.com.cn.
  • Department of Thoracic Surgery, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China huang.xiaowu@zs-hospital.sh.cn sysuncml@163.com lihecheng2000@hotmail.com qf12486@rjh.com.cn.
  • Key Laboratory of Carcinogenesis and Cancer Invasion, Zhongshan Hospital Fudan University, Shanghai, China huang.xiaowu@zs-hospital.sh.cn sysuncml@163.com lihecheng2000@hotmail.com qf12486@rjh.com.cn.

Förderung

  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Yangfan Project of Shanghai

Zitieren

APA

Li, J., Ye, X., Su, S., Hu, Z., Chen, C., Gong, Y., Li, Z., Qi, F., Li, H., Mao, L., & Huang, X. (2026). Tumor neoantigen gene C7orf50 remodels the immune microenvironment by recruiting tumor-associated macrophages to promote hepatocellular carcinoma progression and lung metastasis. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2025-011997

Vancouver

Li J, Ye X, Su S, Hu Z, Chen C, Gong Y, et al. Tumor neoantigen gene C7orf50 remodels the immune microenvironment by recruiting tumor-associated macrophages to promote hepatocellular carcinoma progression and lung metastasis. Journal for ImmunoTherapy of Cancer. 2026. doi:10.1136/jitc-2025-011997

BibTeX
@article{Li2026,
  author = {Li, Jia and Ye, Xinming and Su, Sheng and Hu, Zhiqiang and Chen, Changzhou and Gong, Yu and Li, Zehuan and Qi, Feng and Li, Hecheng and Mao, Li and Huang, Xiaowu},
  title = {Tumor neoantigen gene C7orf50 remodels the immune microenvironment by recruiting tumor-associated macrophages to promote hepatocellular carcinoma progression and lung metastasis},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  doi = {10.1136/jitc-2025-011997}
}
Kostenlos starten →